Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Disease-specific tools better assess quality of life in alopecia areata patients.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

The visfatin GT genotype may increase the risk of Alopecia Areata.

These gene variations are not linked to alopecia areata in Egyptians.

Four genes are linked to alopecia areata, with two increasing risk and two offering protection.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Early diagnosis and treatment of alopecia areata in children is crucial to prevent severe progression.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

Oxidative stress is important in causing alopecia areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Higher antigliadin antibody levels are linked to alopecia areata severity.